Clinical outcomes of bulky parotid gland cancers: need for self-examination and screening program for early diagnosis of parotid tumors
Open Access
- 18 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 21 (1), 1-9
- https://doi.org/10.1186/s12885-021-07902-9
Abstract
Early detection and diagnosis of parotid gland cancer (PGC) are essential to improve clinical outcomes, because Tumor-Node-Metastasis stage at diagnosis is a very strong indicator of prognosis in PGC. Nevertheless, some patients still present with large parotid mass, maybe due to the unawareness or ignorance of their disease. In this study, we aimed to present the clinical outcomes of bulky PGC (defined by a 4 cm cutoff point for T3–4 versus T1–2 tumors), to emphasize the necessity of a self-examination tool for parotid gland tumor. We retrospectively reviewed 60 consecutive cases with bulky (equal to and greater than 4 cm in the longest diameter, determined radiologically) malignant tumors arising from the parotid gland from 1995 to 2016. The clinical and pathological factors were analyzed to identify risk factors for poor outcomes using Cox proportional hazard models. In addition, we designed a self-examination tool for parotid gland tumors, similar to breast self-examination for breast cancer detection. Patients with bulky parotid cancer showed 48.9% 5-year and 24.5% 10-year overall survival rates and a 47.9% risk of high-grade malignancy. The common pathological diagnoses were carcinoma ex pleomorphic adenoma (18.3%), adenocarcinoma (16.7%), mucoepidermoid carcinoma (16.7%), salivary duct carcinoma (16.7%), and adenoid cystic carcinoma (11.7%). Survival analyses revealed that tumor size (hazard ratio, HR = 1.262 upon increase of 1 cm, 95% confidence interval, 95%CI 1.059–1.502), lymph node metastasis (HR = 2.999, 95%CI 1.048–8.583), and high tumor grade (HR = 4.148, 95%CI 1.215–14.154) were independent prognostic factors in multivariable analysis. Functional preservation of the facial nerve was possible only in less than half of patients. In bulky PGC, lymph node metastasis at diagnosis and high tumor grade indicated poor survival outcomes, and functional outcomes of the facial nerve were suboptimal. Thus, a public effort seems to be necessary to decrease these patients with bulky PGC, and to increase patients’ self-awareness of their disease. As a way of early detection, we proposed a parotid self-examination tool to detect parotid gland tumors at an early stage, which is similar to breast self-examination.Keywords
Funding Information
- Ministry of Education, Science and Technology (2018R1A2B6002920)
This publication has 26 references indexed in Scilit:
- Treatment outcomes in metastatic and localized high-grade salivary gland cancer: high chance of cure with surgery and post-operative radiation in T1–2 N0 high-grade salivary gland cancerBMC Cancer, 2018
- Salivary duct carcinoma: Treatment, outcomes, and patterns of failureHead & Neck, 2015
- Postoperative Nomograms Predictive of Survival After Surgical Management of Malignant Tumors of the Major Salivary GlandsAnnals of Surgical Oncology, 2013
- Parotid tumor size predicts proximity to the facial nerveThe Laryngoscope, 2011
- Electrophysiologic facial nerve monitoring during parotidectomyHead & Neck, 2009
- Carcinoma of the parotid glandThe American Journal of Surgery, 2003
- Facial nerve function after partial superficial parotidectomy: An 11‐year review (1987‐1997)Otolaryngology -- Head and Neck Surgery, 1999
- Tumours of the parotid gland: the significance of tumour size and facial nerve involvement.1979
- Estimated Effect of Breast Self-Examination and Routine Physician Examinations on Breast-Cancer MortalityThe New England Journal of Medicine, 1978
- Breast Self-Examination Practices and Breast-Cancer StageThe New England Journal of Medicine, 1978